Cite
Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody.
MLA
Bähr-Mahmud, Hayat, et al. “Preclinical Characterization of an MRNA-Encoded Anti-Claudin 18.2 Antibody.” OncoImmunology, vol. 12, no. 1, Jan. 2023, pp. 1–9. EBSCOhost, https://doi.org/10.1080/2162402X.2023.2255041.
APA
Bähr-Mahmud, H., Ellinghaus, U., Stadler, C. R., Fischer, L., Lindemann, C., Chaturvedi, A., Diekmann, J., Wöll, S., Biermann, I., Hebich, B., Scharf, C., Siefke, M., Roth, A. S., Rao, M., Brettschneider, K., Ewen, E.-M., Şahin, U., & Türeci, Ö. (2023). Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody. OncoImmunology, 12(1), 1–9. https://doi.org/10.1080/2162402X.2023.2255041
Chicago
Bähr-Mahmud, Hayat, Ursula Ellinghaus, Christiane R. Stadler, Leyla Fischer, Claudia Lindemann, Anuhar Chaturvedi, Jan Diekmann, et al. 2023. “Preclinical Characterization of an MRNA-Encoded Anti-Claudin 18.2 Antibody.” OncoImmunology 12 (1): 1–9. doi:10.1080/2162402X.2023.2255041.